Hemab Therapeutics Holdings, Inc. - Common Stock (NQ:COAG)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
29.1% below 52-week high
39.29
23.0052W Low
55.4252W High
1 Week
6.3% below 1-week high
37.581W Low
41.921W High
Hemab Therapeutics Holdings, Inc. - Common Stock (COAG) traded between $23.00 and $55.42 over the past 52 weeks and last traded at $39.29, 29.1% below its 52-week high. Over the past week it ranged between $37.58 and $41.92.
Past 12 Months
1W
+$0.23
1M
+$3.95
3M
-$9.87
6M
+$13.40
YTD
+$5.29
1Y
+$5.29
COAG was +15.6% over the past year, +51.8% over six months, +15.6% year to date, +0.6% in the last week.
12 Months vs Market
COAG
DIA
SPY
QQQ
IWM
Over the past 12 months COAG returned +15.6% versus DIA (Dow) +5.0%, SPY (S&P 500) +5.7%, QQQ (Nasdaq 100) +3.9% and IWM (Russell 2000) +12.0%.
Volume & Liquidity
0.71× 3-mo avg
Today 347,016
3-mo avg 491.6K
1W
1M
3M
6M
YTD
1Y
COAG most recently traded 347,016 shares against a 3-month average daily volume of 491.6K. More NewsRead MoreFrequently Asked QuestionsIs Hemab Therapeutics Holdings, Inc. - Common Stock publicly traded?
Yes, Hemab Therapeutics Holdings, Inc. - Common Stock is publicly traded.
What exchange does Hemab Therapeutics Holdings, Inc. - Common Stock trade on?
Hemab Therapeutics Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Hemab Therapeutics Holdings, Inc. - Common Stock?
The ticker symbol for Hemab Therapeutics Holdings, Inc. - Common Stock is COAG on the Nasdaq Stock Market
What is the current price of Hemab Therapeutics Holdings, Inc. - Common Stock?
The current price of Hemab Therapeutics Holdings, Inc. - Common Stock is 39.29
When was Hemab Therapeutics Holdings, Inc. - Common Stock last traded?
The last trade of Hemab Therapeutics Holdings, Inc. - Common Stock was at 11/20/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|